Select Biotechnolgy PortFBIOX
13F holders, Q1 2026 (March 31)3holders +1
1new positions
0sold out
$25.04avg. 13F price*
At the end of Q1 2026, 3 institutions reported holding Select Biotechnolgy Port (FBIOX) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were McIlrath & Eck, LLC ($22K), Financial Gravity Asset Management, Inc. ($12K) and Coston, McIsaac & Partners ($1K).
- Company
- Select Biotechnolgy Port
- Filed as
- FIDELITY SELECT BIOTECHNOLOGY (Q1 2026)
- CUSIP
- 316390772
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $22K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 862 shares bought, net +862 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| McIlrath & Eck, LLC | 0.00% | New | 862 | $22K |
| Financial Gravity Asset Management, Inc. | 0.00% | No change | 487 | $12K |
| Coston, McIsaac & Partners | 0.00% | No change | 73 | $1K |
"% of holder's portfolio" is FBIOX's weight in each manager's 13F, not the share of Select Biotechnolgy Port the manager owns.